Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amphotericin (lipid formulation) 50mg powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amphotericin B liposome |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin (lipid formulation) 100mg powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin (lipid formulation) 5mg/mL suspension for injection 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin (lipid formulation) 5mg/mL suspension for injection 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amphotericin B liposome in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B phospholipid complex (substance) |
Is a |
False |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B liposome only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B liposome only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B cholesteryl sulfate complex |
Is modification of (attribute) |
True |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B phospholipid complex (substance) |
Is modification of (attribute) |
True |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B lipid complex |
Is modification of (attribute) |
True |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amphotericin B liposome 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amphotericin B liposome 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B liposome 50 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B liposome 50 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Amphotericin B liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |